Development of technology for next generation closed-loop precision therapy for seizure control in epilepsy using photopharmacology and optogenetics Ghent University
Epilepsy affects upwards of 1% of the population of which 30% are resistant to medical treatment. Because standard antiepileptic drugs affect the entire nervous system, and do so chronically, there are serious and chronic side effects. In this project, I will develop ‘closed-loop precision therapy’ technology for epilepsy, using novel photopharmacological and optogenetic methods. Photopharmacology relies on light sensitive drugs, which are ...